Arcus Biosciences, Inc. · NYSE:RCUS
Jaen Juan C. sold 31,431 Arcus Biosciences, Inc. shares (Form 4)
Traded Jun 22 to Jun 24, 2026 · Filed Jun 24, 2026
From Jun 22 to Jun 24, 2026, Jaen Juan C. (President) sold 31,431 Arcus Biosciences, Inc. shares at an average US$27.92 for US$878K under a trading plan, leaving 890,809 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 31,431 shares
- Price
- US$27.92 average (US$27.03 to US$29.66)
- Value
- US$878K
- Holding after
- 890,809 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Sale | 9,236 | US$27.03 | 913,004 | Indirect |
| Jun 23, 2026 | Common Stock | Sale | 14,067 | US$27.69 | 898,937 | Indirect |
| Jun 23, 2026 | Common Stock | Sale | 1,697 | US$28.06 | 897,240 | Indirect |
| Jun 24, 2026 | Common Stock | Sale | 6,431 | US$29.66 | 890,809 | Indirect |
Source
Related
- Arcus Biosciences, Inc.
- Jaen Juan C.
- Arcus Biosciences, Inc. shareholders
- Form 4 · Jaen Juan C. · Jul 13, 2026
- Form 4 · Azoy Alexander · Aug 24, 2026
- Schedule 13D/A · Gilead Sciences, Inc. · Aug 7, 2026
- Form 4 · Lambert Nicole · Jun 12, 2026
- Form 4 · Machado Patrick · Jun 12, 2026
- Form 4 · Kaneko Yasunori · Jun 12, 2026